OR2L13 and triple-A syndrome: Mice with AAA demonstrated enhanced platelet reactivity in which a D-flow environment pathologically appeared compared with sham-operated mice with S-flow, reaching a plateau at 3 weeks and then dissipating at 4 weeks coincident with increasing platelet surface OR2L13 expression (Figure 8, B–D).